Vannucci, S. and Hagberg, H. Hypoxia-ischemia in the immature brain. J. Exp. Biol.
207 (2004) 3149–3154.
Coyle, J.T. and Puttfarcken, P. Oxidative stress, glutamate and neurodegenerative disorders. Science
262 (1993) 689–695.
Mattson, M.P., Duan, W., Pedersen, W.A. and Culmsee, C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis
6 (2001) 69–81.
Behl, C., Davis, J.B., Lesley, R. and Schubert, D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell
77 (1994) 817–827.
Tan, S., Wood, M. and Maher, P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem.
71 (1998) 95–105.
Tan, S., Schubert, D. and Maher, P. Oxytosis: A novel from of programmed cell death. Curr. Top. Med. Chem.
1 (2001) 497–506.
Maher, P. and David, J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci.
16 (1996) 6394–6401.
Satoh, T., Nakatsuka, D., Watanabe, Y., Nagata, I., Kikuchi, H. and Namura, S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett.
288 (2000) 163–166.
Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M.R., Johnson, J.W. and DeFranco, D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem.
275 (2000) 12200–12206.
Robinson, M.J. and Cobb, M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol.
9 (1997) 180–186.
Wilkinson, M.G. and Millar, J.B. SAPKs and transcription factors do the nucleocytoplasmic tango. Genes Dev.
12 (1998) 1391–1397.
Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science
270 (1995) 1326–1331.
Sgambato, V., Pages, C., Rogard, M., Besson, M.J. and Caboche, J.J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci.
18 (1998) 8814–8825.
Stanciu, M. and DeFranco, D.B. Prolonged nuclear retention of activated extracellular signal-regulated kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem.
277 (2002) 4010–4017.
Levinthal, D.J. and DeFranco, D.B. Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation. J. Biol. Chem.
279 (2004) 11206–11213.
Morimoto, B.H. and Koshland, D.E. Induction and expression of long and short term neurosecretory potentiation in a neural cell line. Neuron
5 (1990) 875–880.
Huber, L.A., Pfaller, K. and Vietor, I. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ. Res.
16 (2003) 962–968.
Levinthal, D.J. and DeFranco, D.B. Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons. J. Biol. Chem.
280 (2005) 5875–5883.
Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K.J. and Cryns, V.L. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Diff.
8 (2001) 443–450.
Davies, C.C., Mason, J., Wakelam, M.J.O., Young, L.S. and Eliopoulos, A.G. Inhibition of phosphatidylinositol 3-kinase and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells. J. Biol. Chem.
279 (2004) 1010–1019.
Wang, L. and Proud, C.G. Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signaling in adult cardiomyocytes. FEBS Lett.
531 (2002) 285–289.